Tandem Autologous versus Single Autologous Transplantation Followed by Allogeneic Hematopoietic Cell Transplantation for Patients with Multiple Myeloma: Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

BACKGROUND: Autologous hematopoietic cell transplantation (HCT) improves survival in patients with multiple myeloma, but disease progression remains a challenge. Allogeneic HCT (alloHCT) has the potential to reduce disease progression through graft-versus-myeloma effects. The aim of the BMT CTN 0102...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Krishnan, Amrita, Pasquini, Marcelo C., Logan, Brent, Stadtmauer, Edward A., Vesole, David H., Alyea, Edwin, Antin, Joseph H., Comenzo, Raymond, Goodman, Stacey, Hari, Parameswaran, Laport, Ginna, Qazilbash, Muzaffar H., Rowley, Scott, Sahebi, Firoozeh, Somlo, George, Vogl, Dan T., Weisdorf, Daniel, Ewell, Marian, Wu, Juan, Geller, Nancy L., Horowitz, Mary M., Giralt, Sergio, Maloney, David G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3611089/
https://ncbi.nlm.nih.gov/pubmed/21962393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70243-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky